You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Litigation Details for CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC. (D.N.J. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC.
The small molecule drug covered by the patents cited in this case is ⤷  Try a Trial .

Details for CORCEPT THERAPEUTICS, INC. v. HIKMA PHARMACEUTICALS USA INC. (D.N.J. 2021)

Date Filed Document No. Description Snippet Link To Document
2021-03-11 1 Complaint United States Patent Nos. 10,195,214 (“the ʼ214 Patent”), 10,500,216 (“the ʼ216 Patent”), 10,842,800 … claims of the ’214 Patent, the ’216 Patent, the ʼ800 Patent, and the ʼ801 Patent are invalid, unenforceable…10,842,800 (“the ʼ800 Patent), and 10,842,801 (“the ʼ801 Patent”) (together, “the patents-in-suit”), owned by … This complaint is an action for patent infringement under the patent laws of the United States, 35 U.S.C…Notice Letter alleges that the claims of the patents-in-suit patent are invalid and/or will not be infringed External link to document
2022-09-27 57 Redacted Document States Patent Nos. 10,195,214, 10,500,216, 10,842,800, and 10,842,801 (together, “the patents-in-suit…product before the patents-in-suit expire, which Corcept alleges is an act of patent infringement under…. Summary of the Claims and Defenses This is a patent infringement case arising from Hikma filing an …counterclaims, seeking declaratory judgments that the patents-in-suit are (1) not infringed and (2) invalid or…2021 9 December 2022 2:21-cv-05034 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2022-12-07 66 Letter infringement of certain claims of United States Patent Nos. 10,195,214; 10,500,216; 10,842,800; and 10,842,801… the expiration of the Asserted Patents was a technical act of patent infringement with respect to one… the Asserted Patents would infringe one or more claims of each of the Asserted Patents unless and to…Court has subject matter jurisdiction over this patent infringement action (the “Action”) and has personal…10,842,801 (together, the “Asserted Patents”) in connection with Hikma’s submission of Abbreviated New Drug External link to document
2022-12-08 67 Judgment infringement of certain claims of United States Patent Nos. 10,195,214; 10,500,216; 10,842,800; and 10,842,801… the expiration of the Asserted Patents was a technical act of patent infringement with respect to one… the Asserted Patents would infringe one or more claims of each of the Asserted Patents unless and to…Court has subject matter jurisdiction over this patent infringement action (the “Action”) and has personal…10,842,801 (together, the “Asserted Patents”) in connection with Hikma’s submission of Abbreviated New Drug External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.